ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $274,000 | -36.9% | 71,512 | -0.4% | 0.28% | +5.6% |
| Q4 2019 | $434,000 | -48.0% | 71,812 | -35.0% | 0.27% | -57.2% |
| Q3 2019 | $835,000 | -37.0% | 110,451 | +12.9% | 0.62% | -41.2% |
| Q2 2019 | $1,325,000 | +35.2% | 97,789 | -45.9% | 1.06% | +49.1% |
| Q1 2019 | $980,000 | +92.2% | 180,787 | +5.3% | 0.71% | +9.1% |
| Q4 2018 | $510,000 | – | 171,687 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |